ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group.

[1]  R. Hildenbrand,et al.  [Captopril in acute myocardial infarct: its effect on infarct size and arrhythmias]. , 2008, Deutsche medizinische Wochenschrift.

[2]  L. Ruilope,et al.  Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  V. Dzau.  Angiotensin converting enzyme inhibitors and the cardiovascular system. , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[4]  D Sumner.  Lies, damned lies--or statistics? , 1992, Journal of hypertension.

[5]  H. Parving,et al.  Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. , 1991, BMJ.

[6]  G. Jerums,et al.  Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. , 1991, BMJ.

[7]  J. Puyana,et al.  Bronchial hyperreactivity and cough induced by angiotensin-converting enzyme-inhibitor therapy. , 1990, The Journal of allergy and clinical immunology.

[8]  M. Weber.  Antihypertensive Treatment: Considerations Beyond Blood Pressure Control , 1989, Circulation.

[9]  C. Berne,et al.  A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. , 1989, The New England journal of medicine.

[10]  A. Morice,et al.  Postmarketing surveillance of enalapril I , 1988 .

[11]  H. Parving,et al.  Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. , 1988, BMJ.

[12]  W. Inman,et al.  Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. , 1988, BMJ.

[13]  R. Stevenson,et al.  Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors , 1988, British medical journal.

[14]  H. Dargie,et al.  Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. , 1987, The New England journal of medicine.

[15]  A. Breckenridge,et al.  PLACEBO-CONTROLLED COMPARISON OF CAPTOPRIL, ATENOLOL, LABETALOL, AND PINDOLOL IN HYPERTENSION COMPLICATED BY INTERMITTENT CLAUDICATION , 1987, The Lancet.

[16]  E. Ferrannini,et al.  Insulin resistance in essential hypertension. , 1987, The New England journal of medicine.

[17]  D. Coulter,et al.  Cough associated with captopril and enalapril. , 1987, British medical journal.

[18]  G. Cocco,et al.  Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris. , 1987, Cardiology.

[19]  A. Sovijärvi,et al.  Comparison of the efficacy of an ACE-inhibitor and a calcium channel blocker in hypertensive asthmatics. A preliminiary report. , 1986, Postgraduate medical journal.

[20]  J. Ruiz,et al.  Captopril and bronchial reactivity. , 1986, Postgraduate medical journal.

[21]  G. Rizzato,et al.  Effects of captopril on hemodynamics and blood gases in chronic obstructive lung disease with pulmonary hypertension. , 1986, Respiration; international review of thoracic diseases.

[22]  B. W. East,et al.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. , 1985, British heart journal.

[23]  P. Weidmann,et al.  Antihypertensive treatment and serum lipoproteins. , 1985, Journal of hypertension.

[24]  M. Catalano,et al.  Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease , 1985, Angiology.

[25]  A. Lechi,et al.  Urinary 6-keto-PGF1 alpha after captopril and indomethacin: possible contribution of PGI2 to the antihypertensive mechanism of ACE inhibitors. , 1985, Advances in prostaglandin, thromboxane, and leukotriene research.

[26]  B. W. East,et al.  Captopril in heart failure. A double blind controlled trial. , 1984, British heart journal.

[27]  J. Rouleau,et al.  Acute effects of captopril on the coronary circulation of patients with hypertension and angina. , 1984, The American journal of medicine.

[28]  C. Dollery,et al.  GLUCOSE INTOLERANCE IN HYPERTENSIVE PATIENTS TREATED WITH DIURETICS; A FOURTEEN-YEAR FOLLOW-UP , 1982, The Lancet.

[29]  L. Klaff,et al.  Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma , 1982 .

[30]  N. Hollenberg,et al.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. , 1980, The Journal of clinical investigation.

[31]  K. Catt,et al.  The Effect of Converting Enzyme Inhibition with SQ20,881 on Plasma and Urinary Kinins, Prostaglandin E, and Angiotensin II in Hypertensive Man , 1979, Hypertension.

[32]  Sklar Sh.  Letter: Herpes simplex. , 1975, Lancet.

[33]  S. Shulman,et al.  Letter: Transfer-factor therapy of chronic active hepatitis. , 1974, Lancet.